Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model.

by Martine Humbert, Nathalie Castéran, Sébastien Letard, Katia Hanssens, Juan Iovanna, Pascal Finetti, François Bertucci, Thomas Bader, Colin D Mansfield, Alain Moussy, Olivier Hermine, Patrice Dubreuil
Published 2010-03-01

Long-term survival analysis of masitinib in amyotrophic lateral sclerosis

by Jesus S. Mora, Walter G. Bradley, Delia Chaverri, María Hernández-Barral, Javier Mascias, Josep Gamez, Gisella M. Gargiulo-Monachelli, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Albert C. Ludolph
Published 2021-07-01

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.

by Patrice Dubreuil, Sébastien Letard, Marco Ciufolini, Laurent Gros, Martine Humbert, Nathalie Castéran, Laurence Borge, Bérengère Hajem, Anne Lermet, Wolfgang Sippl, Edwige Voisset, Michel Arock, Christian Auclair, Phillip S Leventhal, Colin D Mansfield, Alain Moussy, Olivier Hermine
Published 2009-09-01